FHL1 gene mutations are associated with reducing body myopathy, X-linked myopathy with postural muscle atrophy, scapuloperoneal myopathy, Emery-Dreifuss muscular dystrophy, and isolated hypertrophic cardiomyopathy. We describe a boy with a family history consistent with X-linked distal myopathy/cardiomyopathy. The boy first presented at age 14 years and was found to have distal wasting and weakness. Echocardiogram revealed hypertrophic cardiomyopathy. Muscle biopsy showed a vacuolar pathology with no reducing bodies. Sequencing of FHL1 revealed a novel hemizygous c.764G>C missense mutation in exon 8. This is the first report of a predominantly distal myopathy with hypertrophic cardiomyopathy occurring secondary to an FHL1 mutation.
ChuPHRuiz-LozanoPZhouQ. Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system. Mech Dev. 2000;95:259–265.
2.
McGrathMJMitchellCACoghillID. Skeletal muscle LIM protein 1 (SLIM1/FHL1) induces α5b 1-integrin-dependent myocyte elongation. Am J Physiol Cell Physiol. 2003;285:1513–1526.
3.
QuinziiCMVuTHMinKC. X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four and-a-half-LIM protein 1. Am J Hum Genet. 2008;82:208–213.
4.
SchesslJColumbusAHuY. Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1. Neuropediatrics. 2010;41:43–46.
5.
SchesslJTaratutoALSewryC. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1. Brain. 2009;132(pt 2):452–464.
6.
SchesslJZouYMcGrathMJ. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest. 2008;118:904–912.
7.
ShalabySHayashiYKNonakaI. Novel FHL1 mutations in fatal and benign reducing body myopathy. Neurology. 2009;72:375–376.
8.
SchoserBGoebelHHJanischI. Consequences of mutations within the C-terminus of the FHL1 gene. Neurology. 2009;73: 543–551.
9.
WindpassingerCSchoserBStraubV. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet. 2008;82:88–99.
10.
ChenDHRaskindWHParsonWW. A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations. J Neurol Sci. 2010;296:22–29.
11.
GueneauLBertrandATJaisJP. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet. 2009;85:338–353.
12.
FriedrichFWWildingBRReischmannS. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum Mol Genet. 2012;21:3237–3254.
13.
SchreckenbachTHennWKressW. Novel FHL1 mutation in a family with reducing body myopathy. Muscle Nerve. 2013;47:127–134.
14.
ShalabySHayashiYKGotoK. Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1). Neuromuscul Disord. 2008;18:959–961.
15.
CowlingBSCottleDLWildingBR. Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord. 2011;21:237–251.
16.
MichelsenJWSewellAKLouisHA. Mutational analysis of the metal sites in a LIM domain. J Biol Chem. 1994;269:11108–11113.
17.
FeldkirchnerSWalterMCMullerS. Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy. Neuromuscul Disord. 2013;23:418–426.
18.
BettsMJRussellRB. Amino Acid Properties and Consequences of Substitutions. Bioinformatics for Geneticists. New York: John Wiley & Sons; 2003:289–316.
19.
KumarPHenikoffSNgPC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–1081.
20.
CottleDLMcGrathMJWildingBR. SLIMMER (FHL1B/KyoT3) interacts with the proapoptotic protein Siva-1 (CD27BP) and delays skeletal myoblast apoptosis. J Biol Chem. 2009;284:26964–26977.
NonakaKSunoharaNIshiuraSSatoyoshiW. Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. J Neurol Sci. 1981;51:141–55.
23.
MiyoshiKKawaiHIwasaM. Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy. Brain. 1986;109(pt 1):31–54.
24.
UddBParthanenJHalonenP. Tibial muscular dystrophy: late adult-onset distal myopathy in 66 Finnish patients. Arch Neurol. 1993;50:604–608.
25.
LaingNGLaingBAMeredithC. Autosomal dominant distal myopathy: linkage to chromosome 14. Am J Hum Genet. 1995;56:422–427.
26.
DuffRMTayVHackmanP. Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. Am J Hum Genet. 2011;88:729–740.
27.
Wallgren-PetterssonCLehtokariVLKalimoH. Distal myopathy caused by homozygous missense mutations in the nebulin gene. Brain. 2007;130(pt 6):1465–1476.
28.
HackmanPViholaAHaravuoriH. Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet. 2002;71:492–500.
29.
SelcenDEngelAG. Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol. 2005;57:269–276.
30.
SelcenDEngelAG. Mutations in myotilin cause myofibrillar myopathy. Neurology. 2004;62:1363–1371.
